Abstract:The loss of dopaminergic neurons in the substantia nigra is a hallmark of pathology in Parkinson’s disease (PD). Dimethylarginine dimethylaminohydrolase-1 (DDAH-1) is the critical enzyme responsible for the degradation of asymmetric dimethylarginine (ADMA) which inhibits nitric oxide (NO) synthase and has been implicated in neurodegeneration. Mitochondrial dysfunction, particularly in the mitochondria-associated endoplasmic reticulum membrane (MAM), plays a critical role in this process, although the specific molecular target has not yet been determined. This study aims to examine the involvement of DDAH-1 in the nigrostriatal dopaminergic pathway and PD pathogenesis. The distribution of DDAH-1 in the brain and its colocalization with dopaminergic neurons were observed. The loss of dopaminergic neurons and aggravated locomotor disability after rotenone (ROT) injection were showed in the DDAH-1 knockout rat. l-arginine (ARG) and NO donors were employed to elucidate the role of NO respectively. In vitro, we investigated the effects of DDAH-1 knockdown or overexpression on cell viability and mitochondrial functions, as well as modulation of ADMA/NO levels using ADMA or ARG. MAM formation was assessed by the Mitofusin2 oligomerization and the mitochondrial ubiquitin ligase (MITOL) phosphorylation. We found that DDAH-1 downregulation resulted in enhanced cell death and mitochondrial dysfunctions, accompanied by elevated ADMA and reduced NO levels. However, the recovered NO level after the ARG supplement failed to exhibit a protective effect on mitochondrial functions and partially restored cell viability. DDAH-1 overexpression prevented ROT toxicity, while ADMA treatment attenuated these protective effects. The declines of MAM formation in ROT-treated cells were exacerbated by DDAH-1 downregulation via reduced MITOL phosphorylation, which was reversed by DDAH-1 overexpression. Together, the abundant expression of DDAH-1 in nigral dopaminergic neurons may exert neuroprotective effects by maintaining MAM formation and mitochondrial function probably via ADMA, indicating the therapeutic potential of targeting DDAH-1 for PD.

Dopamine Prevents Lipid Peroxidation-Induced Accumulation of Toxic Α-Synuclein Oligomers by Preserving Autophagy-Lysosomal Function

Inhibition of Α‐synuclein Fibrillization by Dopamine Analogs Via Reaction with the Amino Groups of Α‐synuclein

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration

Α-Lipoic Acid Protects Dopaminergic Neurons Against MPP+-induced Apoptosis by Attenuating Reactive Oxygen Species Formation.

Dopamine Auto-Oxidation Aggravates Non-Apoptotic Cell Death Induced by Over-Expression of Human A53t Mutant Alpha-Synuclein in Dopaminergic Pc12 Cells

Suppression of Abnormal Α-Synuclein Expression by Activation of BDNF Transcription Ameliorates Parkinson's Disease-Like Pathology.

The Effect of Oxidized Dopamine on the Structure and Molecular Chaperone Function of the Small Heat-Shock Proteins, αB-Crystallin and Hsp27

Impact of dopamine oxidation on dopaminergic neurodegeneration.

Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's disease

Nutrient Deprivation Induces Α-Synuclein Aggregation Through Endoplasmic Reticulum Stress Response and SREBP2 Pathway.

Prevention of Dopamine-Induced Cell Death by Thiol Antioxidants: Possible Implications for Treatment of Parkinson's Disease

α-Synuclein oligomers induce the loss of dopaminergic neurons via mitochondrial dysfunction and oxidative stress in an intragastric rotenone mouse model of Parkinson’s disease

Α‐synuclein Stimulation of Monoamine Oxidase‐b and Legumain Protease Mediates the Pathology of Parkinson's Disease

Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

Complicated Function of Dopamine in Aβ-related Neurotoxicity: Dual Interactions with Tyr10 and SNK(26–28) of Aβ

Endogenous dopamine (DA) renders dopaminergic cells vulnerable to challenge of proteasome inhibitor MG132.

Lipoic Acid Protects Dopaminergic Neurons in LPS-induced Parkinson's Disease Model.

Adenosine Monophosphate-Activated Protein Kinase Overactivation Leads to Accumulation of Α-Synuclein Oligomers and Decrease of Neurites

DDAH-1 Maintains Endoplasmic Reticulum-Mitochondria Contacts and Protects Dopaminergic Neurons in Parkinson’s Disease

Aldehyde Dehydrogenase 1 Defines and Protects a Nigrostriatal Dopaminergic Neuron Subpopulation.

Neuroinflammation and Oxidation/Nitration of Alpha-Synuclein Linked to Dopaminergic Neurodegeneration